Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30066179HIVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20010255HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20009841HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20008509HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20010233HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20061216HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20030399HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20044743HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20023606HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS44013679HTLV-1ENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TCGA Plot Options
Drug Information
GeneIGF2R
DrugBank IDDB16708
Drug NameCipaglucosidase alfa
Target IDBE0003623
UniProt IDP11717
Regulation Typeligand
PubMed IDs30843882; 37184753
CitationsXu S, Lun Y, Frascella M, Garcia A, Soska R, Nair A, Ponery AS, Schilling A, Feng J, Tuske S, Valle MCD, Martina JA, Ralston E, Gotschall R, Valenzano KJ, Puertollano R, Do HV, Raben N, Khanna R: Improved efficacy of a next-generation ERT in murine Pompe disease. JCI Insight. 2019 Mar 7;4(5). pii: 125358. doi: 10.1172/jci.insight.125358. eCollection 2019 Mar 7.@@Blair HA: Cipaglucosidase Alfa: First Approval. Drugs. 2023 Jun;83(8):739-745. doi: 10.1007/s40265-023-01886-5.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL